Keyphrases
Chemotherapy
100%
Biochemical Mechanism
100%
Cancer Diagnosis
100%
Mechanism of Action
100%
Chemotherapy Agents
100%
Premature Ovarian Insufficiency
100%
Radiotherapy
60%
Cytotoxic Agents
40%
High Incidence
40%
Irradiation
40%
Alkylating Agents
40%
Stem Cells
20%
Survival Rate
20%
Mitotic Inhibitors
20%
Chemotherapy Drugs
20%
Mitochondria
20%
Vascular Endothelial Growth Factor
20%
Bone Marrow Transplantation
20%
Monoclonal Antibody
20%
Cyclophosphamide
20%
Time-to-treatment
20%
Counseling
20%
Threshold Dose
20%
Antibody Targeting
20%
Comprehensive Assessment
20%
Female Fertility
20%
Bevacizumab
20%
Targeted Therapy
20%
Cranium
20%
Topoisomerase Inhibitors
20%
Hypothalamic-pituitary Axis
20%
Granulosa Cells
20%
10-year Survival
20%
Future Fertility
20%
Ovarian Cells
20%
Uterus
20%
Antimetabolites
20%
High-dose Chemotherapy
20%
Pediatric Cancer
20%
Reproductive Age
20%
Biological Agents
20%
Primordial Oocyte
20%
Ovarian Granulosa Cells
20%
Fertility Rate
20%
Fractionation Schedules
20%
Thiotepa
20%
Oocyte Death
20%
Antitumor Antibiotic
20%
Life Decisions
20%
Metabolically Active Cells
20%
Mitochondrium
20%
Medicine and Dentistry
Cancer Diagnosis
100%
Chemotherapy Agent
100%
Primary Ovarian Insufficiency
100%
Radiation Therapy
60%
Oocyte
40%
Alkylating Antineoplastic Agent
40%
Granulosa Cell
40%
Cytotoxic Agent
40%
Malignant Neoplasm
20%
Survival Rate
20%
DNA Cross Linking
20%
Mitochondrion
20%
Cyclophosphamide
20%
Bone Marrow Transplantation
20%
Monoclonal Antibody
20%
Targeted Therapy
20%
Hypothalamus
20%
Counseling
20%
Pediatric Cancer
20%
Female Fertility
20%
Bevacizumab
20%
Biological Product
20%
Vasculotropin A
20%
Antimetabolite
20%
High Dose Chemotherapy
20%
Topoisomerase Inhibitor
20%
Antineoplastic Antibiotic
20%
Thiotepa
20%
Mitotic Inhibitor
20%
Stem Cell
20%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Chemotherapy
100%
Chemotherapy Agent
100%
Premature Ovarian Failure
100%
Alkylating Agent
40%
Cytotoxic Agent
40%
Survival Rate
20%
Vasculotropin A
20%
Monoclonal Antibody
20%
Cyclophosphamide
20%
Biological Product
20%
Antimetabolite
20%
Bevacizumab
20%
DNA Topoisomerase Inhibitor
20%
High Dose Chemotherapy
20%
Antineoplastic Antibiotic
20%
Thiotepa
20%